Written Question·Department for Science, Innovation and Technology·UIN 182341
Immunosuppression: Vaccination
Tabled: 24 April 2023
Answered: 3 May 2023
Question
Vicky Foxcroft
Labour — Lewisham North
To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the potential merits of establishing a UK vaccinology network to research immunogenicity, mucosal immunity, and vaccines for people with compromised immune systems.
Answer
George FreemanThe Life Sciences Vision committed the Government to delivering a Vaccines Healthcare Mission which will build on the UK’s deep expertise in vaccines to strengthen the UK life sciences ecosystem, with a particular focus on new and novel technologies. This will include maximising the opportunities to continue to improve core immunology, vaccinology and clinical trial design and infrastructure as well as deepening expertise in vaccine formulation and delivery.